Open access · CC-BY
via OpenAlex
Spermidine in Colorectal cancer: friend or foe?
Sonia Coni, Rosa Bordone, Luca Campea, Shohei Ohno, Gianluca Canettieri, Enzo Agostinelli
Amino Acids · 2026
Abstract
Colorectal cancer (CRC) is a leading cause of cancer-related mortality, and its incidence is rising among individuals, especially young, underscoring the need for novel therapeutic strategies. CRC development is driven by genetic and epigenetic alterations in key oncogenic pathways and is accompanied by profound reprogramming of polyamine metabolism. In this context, spermidine (SPD), a central polyamine produced downstream of the MYC-ODC axis, is regarded as a pro-tumorigenic metabolite that sustains CRC growth by fueling eIF5A hypusination and MYC translation, thereby establishing a feed-forward MYC-ODC-polyamine-eIF5A circuit that promotes tumorigenesis. Recent studies also show that combined inhibition of polyamine biosynthesis and eIF5A hypusination synergistically impairs MYC translation and suppresses CRC growth in preclinical models, outperforming single-agent strategies such as ornithine decarboxylase (ODC) blockade with difluoromethylornithine (DFMO) and highlighting the translational potential of dual targeting of this axis. Conversely, other lines of evidence indicate that excessive SPD or altered flux through the polyamine pathway can be cytotoxic: multiple reports demonstrate that high-dose SPD triggers apoptosis, while experimental models suggest that SPD and epithelial eIF5A hypusination can protect against colitis and colitis-associated cancer by supporting the translation of detoxifying enzymes. Overall, the literature points to a dual role of SPD, and the aim of this review is to dissect the functions of SPD in CRC, to summarize and critically discuss the potential benefits of this polyamine, and to evaluate how it might be rationally exploited as a therapeutic agent in cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s00726-026-03554-w
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Coni, S., Bordone, R., Campea, L., Ohno, S., Canettieri, G., & Agostinelli, E. (2026). Spermidine in Colorectal cancer: friend or foe?. <em>Amino Acids</em>. https://doi.org/10.1007/s00726-026-03554-w
Vancouver
Coni S, Bordone R, Campea L, Ohno S, Canettieri G, Agostinelli E. Spermidine in Colorectal cancer: friend or foe?. Amino Acids. 2026. doi:10.1007/s00726-026-03554-w.
BibTeX
@article{sonia2026Spermi,
title = {Spermidine in Colorectal cancer: friend or foe?},
author = {Sonia Coni and Rosa Bordone and Luca Campea and Shohei Ohno and Gianluca Canettieri and Enzo Agostinelli},
journal = {Amino Acids},
year = {2026},
doi = {10.1007/s00726-026-03554-w},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Amino acids 2026
Open access · OA
Spermidine in Colorectal cancer: friend or foe?
Frontiers in Nutrition 2019
Open access · CC-BY
Dietary and Gut Microbiota Polyamines in Obesity- and Age-Related Diseases
EMBO Molecular Medicine 2016
Open access · OA
Gut microbiota influences pathological angiogenesis in obesity‐driven choroidal neovascularization
Journal of Osteoporosis 2023
Open access · CC-BY
The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model
Expert Opinion on Therapeutic Patents 2002
Citation only
Novel therapies for sarcopenia: ameliorating age-related changes in skeletal muscle
Nanotheranostics 2025
Open access · CC-BY